Sygnis Pharma Ag

(SYGWF)

By |

Profile

SYGNIS AG is engaged in the development of novel, superior tools for molecular biology. Its developed products include SensiPhi/QualiPhi, a novel DNA polymerase licensed to QIAGEN.

Contact Information

Website: www.sygnis.de
Email: investors@sygnis.de
Main Phone: +49 32221091975
Address: Waldhofer Strasse 104
City / Town: Heidelberg
Country: DEU
Postal Code: 69123

Issuer Information

Exchange: GREY
Employees: 21
$ 1.70 $ 0.23 (15.65%)
Last Price 1.70 Change $ 0.23 Change % 15.65 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 1.70 High 1.70 Low 1.70 Prev Close 1.47
Last Trade Volume 500 52 Wk Hi 1.87 52 Wk Low 1.47
Market Cap 36.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,622,091.00 EPS (TTM) -0.21 PE Ratio N/A Exchange Greys

News